In potential cancer breakthrough, newly found 'kill switch' triggers death of cancer cells: 'One-two punch'
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
Source: fox5ny.com
Stay updated with breaking news from Cell Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The receptor, called CD95, could improve the effectiveness of immune-based therapies.
The CD95 receptor can be used alongside immunotherapy to kill cancer cells By KATIE HELLMAN — science@theaggie.org Researchers from the UC Davis